Mankind Pharma Limited Depreciation And Amortization for the year ending March 31, 2025: USD 72.70 M

Mankind Pharma Limited Depreciation And Amortization is USD 72.70 M for the year ending March 31, 2025, a 52.25% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • Mankind Pharma Limited Depreciation And Amortization for the year ending March 31, 2024 was USD 47.75 M, a 20.43% change year over year.
  • Mankind Pharma Limited Depreciation And Amortization for the year ending March 31, 2023 was USD 39.65 M, a 80.68% change year over year.
  • Mankind Pharma Limited Depreciation And Amortization for the year ending March 31, 2022 was USD 21.94 M, a 35.06% change year over year.
  • Mankind Pharma Limited Depreciation And Amortization for the year ending March 31, 2021 was USD 16.25 M, a 23.60% change year over year.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased